The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis

American Journal of Rhinology

Volumn 22, Issue 6, 2008, Pages 560-567

  Le, Tong ^a   Psaltis, Alkis ^a   Tan, Lor Wai ^a   Wormald, Peter John ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Antibiofilm; Biofilms; Chronic rhinosinusitis; Citric acid; Confocal microscopy; Fluorescence in situ hybridization; Gallium nitrate; Mupirocin; Treatment; Zwitterionic surfactant

Indexed keywords

CITRIC ACID; GALLIUM NITRATE; PSEUDOMONIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; COLONY FORMING UNIT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FRONTAL SINUS; NONHUMAN; NOSE MUCOSA; RHINOSINUSITIS; SHEEP; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS;

ANIMALS; BIOFILMS; CITRIC ACID; COLONY-FORMING UNITS ASSAY; GALLIUM; MUPIROCIN; PEPTIDE NUCLEIC ACIDS; RHINITIS; SHEEP; SINUSITIS; SURFACE-ACTIVE AGENTS;

EID: 59849091487     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2008.22.3232     Document Type: Article

References (29)

1. Ramadan HH, Sanclement JA, and Thomas JG. Chronic rhinosinusitis and biofilms. Otolaryngol Head Neck Surg 132:414-417, 2004.
2. Ferguson BJ, and Stolz DB. Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol 19:452-457, 2005.
3. Sanclement JA, Webster P, and Thomas J. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 115:578-582, 2005.
4. Sanderson AR, Leid JG, and Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 116:1121-1126, 2006.
5. Ha KR, Psaltis AJ, and Tan LW. A sheep model for the study of biofilms in rhinosinusitis. Am J Rhinol 21:339-345, 2007.
6. Psaltis AJ, Ha KR, and Beule AG. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 117:1302-1306, 2007.
7. Psaltis AJ, Weitzel E, and Wormald P-J. The effect of biofilms on post-sinus surgical outcomes. Am J Rhinol 22:1-6, 2008.
8. Bendouah Z, Barbeau J, Hamad WA, et al. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 134:991-996, 2006.
9. Bjarnsholt T, and Givskov M. Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos Trans R Soc Lond B Biol Sci 362:1213-1222, 2007.
10. Hentzer M, Eberl L, and Nielsen J. Quorum sensing: A novel target for the treatment of biofilm infections. Biodrugs 17: 241-250, 2003.
11. Pitt WG, McBride MO, and Lunceford JK. Ultrasonic enhancement of antibiotic action on gram-negative bacteria. Antimicrob Agents Chemother 38:2577-2582, 1994.
12. Rediske AM, Roeder BL, and Brown MK. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: An in vivo model. Antimicrob Agents Chemother 43:1211-1214, 1999.
13. Costerton JW, Ellis B, and Lam K. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother 38:2803-2809, 1994.
14. Wattanakaroon W, and Stewart PS. Electrical enhancement of streptococcus gordonii biofilm killing by gentamicin. Arch Oral Biol 45:167-171, 2000.
15. Domenico P, Baldassari L, Schoh PE, et al. Activities of bismuth thiols against staphylococci and staphylococcal biofilms. Antimicrob Agents Chemother 45:1417-1421, 2001.
16. Ha KR, Psaltis AJ, Butcher AR, et al. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 118:535-540, 2008.
17. Sutherland R, Boon RJ, and Griffin KE. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother 27:495-498, 1985.
18. Capobianco JO, Doran CC, and Goldman RC. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob Agents Chemother 33:156-163, 1989.
19. Hill RL. The bioavailability of mupirocin in nasal secretions in vitro. J Clin Pathol 55:233-235, 2002.
20. van Rijen MM, Bonten M, Wenzel RP, et al. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: A systematic review. J Antimicrob Chemother 61:254-261, 2008.
21. Davis SC, Ricotti C, Cazzaniga A, et al. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 16:23-29, 2008.
22. Ishikawa J, and Horii T. Effects of mupirocin at subinhibitory concentrations on biofilm formation in Pseudomonas aeruginosa. Chemotherapy 51:361-362, 2005.
23. Solares CA, Bantra PS, Hall GS, et al. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 27:161-165, 2006.
24. Donlan RM, and Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167-193, 2002.
25. Desrosiers M, Myntti M, James G. Methods for removing bacterial biofilms: In vitro study using clinical rhinosinusitis specimens. Am J Rhinol 21:527-532, 2007.
26. Bhandari M, Schemitsch EH, and Adili A. High and low pressure pulsatile lavage of contaminated tibial fractures: An in vitro study of bacterial adherence and bone damage. J Orthop Trauma 13: 526-533, 1999.
27. Dirschl DR, Duff GP, and Dahners LE. High pressure pulsatile irrigation of fresh fractures: Effects on fracture healing. J Orthop Trauma 12:460-463, 1998.
28. Bullen JJ, Rogers HJ, and Spalding PB. Iron and infection: The heart of the matter. FEMMS Immunol Med Microbiol 43:325-330, 2005.
29. Kaneko Y, Thoendel M, and Olakanmi O. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Investig 117:877-888, 2007.